{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:30:08Z","timestamp":1794623408518,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"publisher","award":["ZYLX202123"],"award-info":[{"award-number":["ZYLX202123"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["DFL20221402"],"award-info":[{"award-number":["DFL20221402"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.tube.2025.102655","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:50:15Z","timestamp":1748919015000},"page":"102655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["In vitro and in vivo antibacterial activity of sudapyridine (WX-081) combined with other drugs against Mycobacterium abscessus"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0896-9149","authenticated-orcid":false,"given":"Hong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.tube.2025.102655_bib1","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1513\/AnnalsATS.201503-173OC","article-title":"The burden of pulmonary nontuberculous mycobacterial disease in the United States","volume":"12","author":"Strollo","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.tube.2025.102655_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3201\/eid2303.161827","article-title":"Epidemiology of nontuberculous mycobacterial lung disease and tuberculosis, Hawaii, USA","volume":"23","author":"Adjemian","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.tube.2025.102655_bib3","first-page":"947","article-title":"A patient-based analysis of the geographic distribution of Mycobacterium avium complex, Mycobacterium abscessus, and Mycobacterium kansasii infections in the United States","volume":"151","author":"Mirsaeidi","year":"2017","journal-title":"Chest (Am Coll Chest Physicians)"},{"issue":"2","key":"10.1016\/j.tube.2025.102655_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1513\/AnnalsATS.201804-236OC","article-title":"Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. Managed care health plan, 2008-2015","volume":"17","author":"Winthrop","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"10.1016\/j.tube.2025.102655_bib5","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1513\/AnnalsATS.201606-474BC","article-title":"Deaths related to nontuberculous mycobacterial infections in the United States, 1999-2014","volume":"13","author":"Vinnard","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.tube.2025.102655_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1513\/AnnalsATS.201303-067OC","article-title":"A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan","volume":"11","author":"Morimoto","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.tube.2025.102655_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0035-1546751","article-title":"Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"36","author":"Park","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.tube.2025.102655_bib8","article-title":"Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation","volume":"173","author":"Jodie","year":"2020","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.tube.2025.102655_bib9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1164\/ajrccm\/147.5.1271","article-title":"Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients","volume":"147","author":"Griffith","year":"1993","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.tube.2025.102655_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01991-2018","article-title":"Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis","volume":"54","author":"Kwak","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.tube.2025.102655_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diagmicrobio.2017.12.008","article-title":"Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease","volume":"90","author":"Choi","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.tube.2025.102655_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/ciw724","article-title":"Mycobacterial characteristics and treatment outcomes in Mycobacterium abscessus lung disease","volume":"64","author":"Koh","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.tube.2025.102655_bib13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.rmed.2010.12.012","article-title":"Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs","volume":"105","author":"Lyu","year":"2011","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.tube.2025.102655_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00175-18","article-title":"Determination of MIC distribution and mechanisms of decreased susceptibility to bedaquiline among clinical isolates of Mycobacterium abscessus","volume":"62","author":"Li","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.tube.2025.102655_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00518-23","article-title":"Sudapyridine (WX-081) antibacterial activity against Mycobacterium avium, Mycobacterium abscessus, and Mycobacterium chelonae in vitro and in vivo","volume":"9","author":"Zheng","year":"2024","journal-title":"mSphere"},{"issue":"11","key":"10.1016\/j.tube.2025.102655_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01225-17","article-title":"Bedaquiline inhibits the ATP synthase in Mycobacterium abscessus and is effective in infected zebrafish","volume":"61","author":"Dupont","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.tube.2025.102655_bib17","doi-asserted-by":"crossref","first-page":"e00114","DOI":"10.1128\/AAC.00114-20","article-title":"Efficacy of bedaquiline, alone or in combination with imipenem, against Mycobacterium abscessus in C3HeB\/FeJ mice","volume":"64","author":"Le Moigne","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.tube.2025.102655_bib18","first-page":"499","article-title":"Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease","volume":"148","author":"Philley","year":"2015","journal-title":"Chest (Am Coll Chest Physicians)"},{"issue":"1","key":"10.1016\/j.tube.2025.102655_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02477-21","article-title":"Sudapyridine (WX-081), a novel compound against Mycobacterium tuberculosis","volume":"10","author":"Yao","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"4","key":"10.1016\/j.tube.2025.102655_bib20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/jac\/dky526","article-title":"A bedaquiline\/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria","volume":"74","author":"Ruth","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.tube.2025.102655_bib21","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1128\/AAC.00459-15","article-title":"Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models","volume":"59","author":"Obregon-Henao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.tube.2025.102655_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02179-20","article-title":"Differential in vitro activities of individual drugs and bedaquiline-rifabutin combinations against actively multiplying and nutrient-starved Mycobacterium abscessus","volume":"65","author":"Lee","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.tube.2025.102655_bib23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/dkaa520","article-title":"In vitro susceptibility of Mycobacterium abscessus complex and feasibility of standardizing treatment regimens","volume":"76","author":"Chew","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.tube.2025.102655_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02234-18","article-title":"In vitro synergism of rifabutin with clarithromycin, imipenem, and tigecycline against the Mycobacterium abscessus complex","volume":"63","author":"Cheng","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.tube.2025.102655_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/antibiotics9020072","article-title":"Rifabutin suppresses inducible clarithromycin resistance in Mycobacterium abscessus by blocking induction of whiB7 and erm41","volume":"9","author":"Aziz","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.tube.2025.102655_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12941-023-00655-2","article-title":"Effectiveness and safety of regimens containing linezolid for treatment of Mycobacterium abscessus pulmonary Disease","volume":"22","author":"Cheng","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.tube.2025.102655_bib27","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3389\/fmicb.2019.01977","article-title":"Clinical efficacy and adverse effects of antibiotics used to treat Mycobacterium abscessus pulmonary disease","volume":"10","author":"Chen","year":"2019","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.tube.2025.102655_bib28","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1183\/09031936.00001913","article-title":"Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients","volume":"42","author":"Bolhuis","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2025.102655_bib29","series-title":"Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes","author":"Woods","year":"2011"},{"issue":"1","key":"10.1016\/j.tube.2025.102655_bib30","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1038\/s41598-017-04108-7","article-title":"A novel protein kinase inhibitor IMB-YH-8 with anti-tuberculosis activity","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.tube.2025.102655_bib31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/infdis\/jit614","article-title":"In vivo evaluation of antibiotic activity against Mycobacterium abscessus","volume":"209","author":"Lerat","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.tube.2025.102655_bib32","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1038\/s41598-020-60452-1","article-title":"A mouse model of pulmonary Mycobacteroides abscessus infection","volume":"10","author":"Maggioncalda","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2025.102655_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1115530","article-title":"Efficacy of PBTZ169 and pretomanid against Mycobacterium avium, Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum in BALB\/c mice models","volume":"13","author":"Zheng","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.tube.2025.102655_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1217975","article-title":"Antibacterial activity of the novel compound Sudapyridine (WX-081) against Mycobacterium abscessus","volume":"13","author":"Nie","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.tube.2025.102655_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01372-22","article-title":"In vitro activity of the sudapyridine (WX-081) against non-tuberculous mycobacteria isolated in Beijing, China","volume":"10","author":"Zhu","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"8","key":"10.1016\/j.tube.2025.102655_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00665-19","article-title":"In vitro activity of bedaquiline and delamanid against nontuberculous mycobacteria, including macrolide-resistant clinical isolates","volume":"63","author":"Kim","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2025.102655_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/IDR.S390187","article-title":"In vitro and intracellular antibacterial activity of sudapyridine (WX-081) against tuberculosis","volume":"16","author":"Xiao","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"7","key":"10.1016\/j.tube.2025.102655_bib38","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3390\/microorganisms10071421","article-title":"Activity of drug combinations against Mycobacterium abscessus grown in aerobic and hypoxic conditions","volume":"10","author":"Lanni","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.tube.2025.102655_bib39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/IDR.S395750","article-title":"Antimicrobial effect of oxazolidinones and its synergistic effect with bedaquiline against Mycobacterium abscessus complex","volume":"16","author":"Gao","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"9","key":"10.1016\/j.tube.2025.102655_bib40","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17460441.2019.1629414","article-title":"Repositioning rifamycins for Mycobacterium abscessus lung disease","volume":"14","author":"Ganapathy","year":"2019","journal-title":"Expet Opin Drug Discov"},{"issue":"5","key":"10.1016\/j.tube.2025.102655_bib41","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jac\/43.5.615","article-title":"Antimycobacterial activities of riminophenazines","volume":"43","author":"Reddy","year":"1999","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.tube.2025.102655_bib42","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.rmed.2009.04.026","article-title":"Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs","volume":"103","author":"Ballarino","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.tube.2025.102655_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128824","article-title":"Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent","volume":"71","author":"Huang","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"10.1016\/j.tube.2025.102655_bib44","doi-asserted-by":"crossref","first-page":"e02404","DOI":"10.1128\/AAC.02404-19","article-title":"TBAJ-876, a 3,5-dialkoxypyridine analogue of bedaquiline, is active against Mycobacterium abscessus","volume":"64","author":"Sarathy","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.tube.2025.102655_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01418-21","article-title":"Impact of dose, duration, and immune status on efficacy of ultrashort telacebec regimens in mouse models of Buruli Ulcer","volume":"65","author":"Komm","year":"2021","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979225000502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979225000502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T15:25:16Z","timestamp":1756913116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979225000502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":45,"alternative-id":["S1472979225000502"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2025.102655","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo antibacterial activity of sudapyridine (WX-081) combined with other drugs against Mycobacterium abscessus","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2025.102655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102655"}}